Potential benefits of gene editing for the future of poultry farming.
CRISPR
Gene editing
Poultry
Regulation
Journal
Transgenic research
ISSN: 1573-9368
Titre abrégé: Transgenic Res
Pays: Netherlands
ID NLM: 9209120
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
entrez:
20
7
2019
pubmed:
20
7
2019
medline:
3
1
2020
Statut:
ppublish
Résumé
The chicken is an exemplar of efficient intensive animal agriculture and provides two valuable food products, chicken meat and eggs. Only aquaculture is better, by efficiency, but poultry is still top, by mass of animal protein produced as food in the global context. However this efficiency and intensive production comes with a number of challenges. Though the genetics of selective breeding have led to dramatic improvements in yield, efficiency and product quality, traits that relate to disease and welfare outcomes have not been so tractable. These two issues are major impacts to the industry in terms of production and in terms of public perception. Both transgenic technology and genome editing have clear potential for impact in these two important areas. The reproductive biology of birds requires techniques very specific to birds to achieve heritable (germline) edited traits. These are quite involved and, even though they are now well-defined and reliable, there is room for improvement and advances can be expected in the future. Currently the key targets for this technology are modifying chicken genes involved in virus-receptor interactions and cellular response involved in infection. For the egg industry the technology is being applied to the issue of sex-selection for layer hens (and the removal of males), removal of allergens from egg white and the tailoring of eggs system to enhance the yield of influenza vaccine doses. Regulation and trading of the animals generated, and resulting food products, will significantly impact the value and future development of genome editing for poultry.
Identifiants
pubmed: 31321689
doi: 10.1007/s11248-019-00139-0
pii: 10.1007/s11248-019-00139-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
87-92Références
Nature. 2012 Nov 1;491(7422):114-8
pubmed: 23000899
Development. 2017 Mar 1;144(5):928-934
pubmed: 28174243
J Reprod Fertil. 1994 Mar;100(2):447-9
pubmed: 8021862
Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12716-21
pubmed: 25139993
Nature. 2006 Jun 8;441(7094):766-9
pubmed: 16760981
Nat Biotechnol. 2013 Mar;31(3):230-2
pubmed: 23360966
Transgenic Res. 2016 Oct;25(5):575-95
pubmed: 27246007
J Virol. 2018 Jul 31;92(16):
pubmed: 29925651
Transgenic Res. 2016 Jun;25(3):307-19
pubmed: 26820412
PLoS One. 2016 Apr 21;11(4):e0154303
pubmed: 27099923
Science. 2013 Feb 15;339(6121):823-6
pubmed: 23287722
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
Transgenic Res. 2013 Dec;22(6):1257-64
pubmed: 23807321
Nutrients. 2017 Feb 21;9(2):
pubmed: 28230769
G3 (Bethesda). 2017 Jan 5;7(1):109-117
pubmed: 27852011
Nature. 2004 Dec 9;432(7018):695-716
pubmed: 15592404
Mamm Genome. 2017 Aug;28(7-8):315-323
pubmed: 28612238
Transgenic Res. 2017 Jun;26(3):331-347
pubmed: 27896535
Sci Rep. 2016 Apr 06;6:23980
pubmed: 27050479
J Virol. 2017 Dec 14;92(1):
pubmed: 29070685